15th Mar 2016 08:38
LONDON (Alliance News) - Healthcare IT company Instem PLC on Tuesday said it has secured two contracts for its Submit product suite worth USD800,000.
The contracts are to commence immediately and will contribute to Instem's 2016 results. The contracts have been signed with two existing customers, neither of which were named but which are large pharmaceutical companies, according to Instem.
"We are delighted to extend our relationship with two existing customers. This provides further evidence of how Instem is starting to benefit from the FDA mandate requiring pre-clinical study submissions to comply with SEND," said Instem Chief Executive Phil Reason.
Instem shares were up 0.1% to 205.11 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
INS.L